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Sciences, Moscow, RussiaABSTRACT In an attempt to reveal the mechanism of rats’ resistance to Alzheimer’s disease, we determined the structure of
the metal-binding domain 1–16 of rat b-amyloid (rat Ab(1–16)) in solution in the absence and presence of zinc ions. A zinc-
induced dimerization of the domain was detected. The zinc coordination site was found to involve residues His-6 and His-14
of both peptide chains. We used experimental restraints obtained from analyses of NMR and isothermal titration calorimetry
data to perform structure calculations. The calculations employed an explicit water environment and a simulated annealing
molecular-dynamics protocol followed by quantum-mechanical/molecular-mechanical optimization. We found that the C-tails
of the two polypeptide chains of the rat Ab(1–16) dimer are oriented in opposite directions to each other, which hinders the
assembly of rat Ab dimers into oligomeric aggregates. Thus, the differences in the structure of zinc-binding sites of human
and rat Ab(1–16), their ability to form regular cross-monomer bonds, and the orientation of their hydrophobic C-tails could be
responsible for the resistance of rats to Alzheimer’s disease.INTRODUCTIONAccording to thewidely accepted amyloid hypothesis (1), the
key pathogenic process of Alzheimer’s disease (AD) is the
transition of soluble b-amyloid (Ab) monomer into neuro-
toxic oligomers and then into insoluble fibrillar polymeric
aggregates, which form the amyloid plaques. The details of
the molecular mechanism of this aggregation remain
unknown; however, it was reported that zinc and copper
ions may play a critical role in this pathological transition
(2,3). Human Ab interacts with zinc ions through its metal-
binding domain 1–16 (4–8), and it has been shown that the
stoichiometry of Zn2þ binding to the soluble forms of human
Ab is 1:1. Three histidine residues (His-6,His-13, andHis-14)
participate in the coordination of the zinc ion (4–7,9–15). The
fourth residue that fills up the Zn2þ coordination sphere was
reported to be eitherAsp-1 (9–11) orGlu-11 (5,10) depending
on the pH and solvent. Theminimal zinc-binding site ofAb in
water was found to consist of residues 6–14 (7). It was also
shown that region 11–14 of the human Ab mediates zinc-
induced conglutination of human Ab (16), which, as ex-
pected, leads to further formation of stable Ab aggregates
with ordered monomer chain packing (17–19).
As opposed to other mammals, rats and mice are invulner-
able to AD (20,21). The key factors in such resistance could
be the three amino acid substitutions (R5G, Y10F, and
H13R) in the metal-binding domain (4,22), which are the
only differences between human and rodent Ab sequences
(Fig. 1). It was found that the coordination of Zn2þ bySubmitted September 7, 2011, and accepted for publication November 23,
2011.
*Correspondence: vpolsha@mail.ru or kozinsa@gmail.com
Editor: Heinrich Roder.
 2012 by the Biophysical Society
0006-3495/12/01/0136/8 $2.00His-13 is critical for zinc-induced aggregation of human
Ab (23). NMR solution studies of rat Ab(1–28) in dimethyl
sulfoxide (DMSO)-d6 (24) and in sodium dodecyl sulfate
(SDS) micelles (10) showed that the affinity of Zn2þ for
rat Ab(1–28) is lower than that for the analogous human
peptide. His-6 and His-14 were identified as the primary
zinc chelators in both media. Additionally, Arg-13 was sug-
gested to bind zinc ion in DMSO-d6 (24). In contrast, the
terminal amino group of Asp-1 and the carboxyl group of
Glu-11 of rat Ab(1–28) were found to bind the zinc ion
when the peptide was solubilized in water/SDS micelles
(10). In this case the authors found that rats and humans
Ab(1–28) exhibited very similar effects upon interaction
with Zn2þ. However, in contrast to the results obtained
with human Ab(1–16) (5), the spatial structures of the rat
Ab species containing the metal-binding domain were
determined in nonphysiological conditions (organic solvent
or SDS micelles), which may compromise accurate compar-
ison of these two species.
To investigate possible molecular mechanisms in rodents’
resistance to pathogenic Ab aggregation, we obtained the
structure of the complex of rat Ab metal-binding domain in
the presence of Zn2þ ions in aqueous solution and at a phys-
iological pH. To determine the amino acids that participate in
zinc ion coordination, we used two independent methods:
NMR and isothermal titration calorimetry (ITC).MATERIALS AND METHODS
All chemicals and solvents were of high-performance liquid chromatog-
raphy grade or better and were obtained from Sigma-Aldrich (St. Louis,
MO). All synthetic peptides (purity > 98% checked by reverse-phase
high-performance liquid chromatography) were purchased fromdoi: 10.1016/j.bpj.2011.11.4006
FIGURE 1 Sequences of human and rat Ab. The metal-binding domain
1–16 is shown by a rectangle. Differences in the amino acid sequences
are marked.
NMR Structure of Rat Ab(1–16) 137Biopeptide, LLC (San Diego, CA). We confirmed the amino acid sequence
of each peptide on an ultrahigh-resolution Fourier transform ion cyclotron
resonance mass spectrometer (7T Apex Qe; Bruker Daltonics, Billerica,
MA) using a de novo sequencing approach based on the collision-induced
dissociation fragmentation technique.Isothermal titration calorimetry
ITC measurements were carried out on an iTC200 instrument (MicroCal,
Northampton, MA) at 25C in 50 mM Tris buffer, pH 7.3. Aliquots of
ZnCl2 solution (2 ml) were injected into the 0.2 mL cell containing the
peptide solution to achieve a complete binding isotherm (Fig. 2 and
Fig. S1 of the Supporting Material). The peptide concentration in the cell
ranged from 0.1 to 1 mM, and the ZnCl2 concentration in the syringe ranged
from 5 to 15 mM. The heat of dilution was measured by injecting the ligand
(ZnCl2) into the buffer solution or by additional injections of the ligand
after saturation; the values obtained were subtracted from the heat of the
reaction to obtain the effective heat of binding. We fitted the resulting titra-
tion curves using MicroCal Origin software (Fig. S1), and determined the
affinity constants (Ka), binding stoichiometry (N), and enthalpy (DH) using
a nonlinear regression fitting procedure. The ITC measurements for each
peptide were repeated at least three times at different peptide concentrations
and yielded similar thermodynamic parameters.NMR experiments
A 5 mM solution of rat Ab(1–16) in a 20 mM Tris-d11 buffer solution (pH
7.1) was used for NMR measurements. We added 0.1% NaN3 to the
samples to prevent peptide biodegradation. We prepared samples of ratFIGURE 2 ITC binding isotherms of zinc interactions with rat Ab(1–16)
(a) and its mutants D1A (b), D7A (c), E3A (d), E11A (e), H14A (f), and
H6A (g) at 25C in 50 mM Tris buffer, pH 7.3.Ab(1–16) in the presence of zinc ions by adding, in several steps, a concen-
trated stock solution of the highest analytical grade ZnCl2 (Aldrich) to the
peptide to achieve a Zn2þ/peptide ratio of ~1.0–1.5. Changes in the chem-
ical shifts of the peptide signals after stepwise addition of ZnCl2 were moni-
tored. The absence of pH variation upon zinc addition was confirmed after
the final addition. NMR spectra were measured at 278 K either in D2O or in
90% H2O/10% D2O on a Bruker AVANCE spectrometer (Bruker, Karls-
ruhe, Germany) operating at 600 MHz 1H frequency, equipped with
a triple-resonance (1H, 13C, and 15N), pulsed-field, z-gradient probe.
Two-dimensional (2D) NMR spectra were processed by NMRPipe (25)
and analyzed with the use of SPARKY (26).NMR signal assignment
We obtained the 1H, 15N, and 13C signal assignments of the rat Ab(1–16)
and its complex with zinc using the following 2D spectra: DQF-COSY,
TOCSY (mixing time of 70 ms), NOESY (mixing time of 200 and
500 ms), 13C-1H HSQC, and 15N-1H HSQC. Heteronuclear experiments
were measured at the natural abundance of the 13C and 15N isotopes
(Fig. S2). For the signal assignments we used the classical approach of
Wuthrich (27) (see Fig. S3 and Fig. S4) supplemented by analysis of the
HSQC spectra. Signal assignments of the free rat Ab(1–16) and its complex
with zinc are presented in Table S1 and Table S2, respectively.Restrained molecular dynamics
We determined the structures of the rat Ab(1–16) and its complex with zinc
ions using a restrained molecular-dynamics (MD) approach with sets of
NOE restraints. Several dihedral angle restraints for the peptide backbone
were determined for the complex of the rat Ab(1–16) with Zn2þ with the
use of AngleSearch software (28). For the zinc-peptide complex, distance
and torsion angle restraints representing the coordination site of the zinc
ion were also used in MD calculations. These parameters were obtained
by quantum-mechanical (QM) geometry optimization (see below). We
identified the His nitrogen atoms that participate in the chelation of the
zinc ion (Nd1 for His-6 and Nε2 for His-14) by analyzing possible orienta-
tions of the His imidazole ring for each type of chelating center, and
comparing the interatomic distances with the observed intensities of the
NOEs. Thus, the stronger intraresidue NOEs of Hd2–HN and Hd2–Ha
for His-14, and the equally strong NOEs for Hd2–Hbs in both His-6 and
His-14 residues (Fig. 3) unambiguously confirm the selection of the
chelating atoms.
Determining the structure of small, charged, and mobile peptides is a rela-
tively difficult task due to the lack of experimentally determined restraints
and their conformational averaging. To obtain reliable structural data, we
carried out MD simulations in explicit water with appropriate calculations
of electrostatic interactions between charged groups of the peptide. The
extended chain conformation of the peptide was used as the initial structure
in MD calculations. A peptide molecule was placed into a cubic cell of
0.5  0.5  0.5 nm, and 13,710 water molecules of the SPC/E model
were added to the system (29). Because the total charge of the system is
zero, neutralization of the molecular system was not required. We mini-
mized the potential energy in two stages, first using the steepest-descent
algorithm and subsequently the conjugated gradient algorithm. We used
GROMACS 3.3.1 software (30) and AMBER 03 force-field (31) for all
calculations. The system obtained after 20 ps of MD trajectory with
restricted positions of all polypeptide atoms was used as the initial structure
in subsequent structure calculations. A Berendsen thermostat and a barostat
with a rescale velocity function were used in the MD calculations. The
lengths of covalent bonds during MD were controlled by the LINCS algo-
rithm (32). The energy of electrostatic interactions was calculated using the
Ewald particles grid algorithm. The maximum distances of the Coulomb
and van der Waals forces were 1.0 and 1.4 nm, respectively. The integration
step for MD calculations was 2  1015 s. Calculations of the rat Ab(1–16)Biophysical Journal 102(1) 136–143
FIGURE 3 Fragments of the 2D NOESY spectrum (200 ms mixing time)
of the complex of rat Ab(1–16) with zinc ions, showing several intraresidue
NOEs involving the Hd2 signals of His-6 and His-14.
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138 Istrate et al.structures were performed according to a previously described protocol
(33). The total length of the MD trajectory was 142 ps, and it took
~16 min to calculate a family of 20 structures using 320 processors. We
determined the convergence of the calculations using the root mean-square
deviation (RMSD) of the coordinates of the C, Ca, and N atoms of protein
chain structures, calculated for the whole family. We defined the quality of
the calculated structures on the basis of the percentage of hits of the main
dihedral angles 4 and j in the most favorable and prohibited areas of a
Ramachandran map using Procheck_NMR (34). Structures were visualized
(see Fig. 5 and Fig. S5) and analyzed with the use of InsightII software
(Accelrys).Quantum-mechanical/molecular-mechanical
calculations
The binding of metal ions to a protein can cause strong polarization and
charge transfer effects and coordination geometries that are not easily
described within standard force fields. In many cases, an adequate simula-
tion can only be performed with an explicit QM electronic-structure calcu-
lation. In addition, the problem of adequate definition of the metal-binding
sites in proteins requires the use of an approach that takes into account the
entire protein environment and incorporates finite temperature effects that
are known to be crucial for biological function (35). To fulfill all of these
conditions, we applied the QM/molecular-mechanical (MM) Car-Parrinello
simulation approach (36,37), which was previously shown to be successful
in simulations of a number of metal-containing systems (38–40). Further-
more, recent results from Zn2þ-Ab complexes obtained by the QM/MM
method showed good agreement with NMR data (16,41,42).
A representative structure of the rat Ab(1–16) peptide complexed to
a zinc ion was used as the starting conformation for QM/MM calculations.
We applied the MM approach using the parameters from the parm99 force
field with corrections by Duan et al. (43). To describe the QM system, we
employed the density functional theory in the generalized gradient approx-
imation using the PW91 functional. The side length of a cubic cell for allo-
cation of the quantum subsystem was set to 45 A˚. The cutoff radius for the
MM calculations was set to 15 A˚, and van der Waals interactions, which are
poorly described by default density functional theory, were corrected with
the Grimme analytical potential (44). Each simulation system was filled
with water molecules presented by the TIP4P model. We equilibrated water
molecules around the peptide-ion complex by carrying out a 100 ps MD
simulation with restrained positions of the peptide and the zinc ion. The
prepared systems were subjected to QM/MM simulations with the use of
the GROMACS/CPMD package (36). The integration time step was
0.12 fs (~5 a.u.). The radius of calculation of close-range, charge-to-charge
interactions was set to 10 A˚. The list of neighboring atoms was renewed at
each step. Long-range charge interactions were calculated with the PME
algorithm (46). Temperature coupling with the Nose-Hover (47,48) scheme
allowed the determination of the systems at body temperature (300 K). The
interactions between valence electrons and ionic cores were described by an
ultrasoft VDB pseudopotential (49,50). Because we applied ultrasoft pseu-
dopotentials, the basis set for the valence electrons consisted of plane waves
expanded up to a cutoff of 30 A˚.RESULTS AND DISCUSSIONS
The NMR spectra of free rat Ab(1–16) contain sharp signals
typical of small monomeric peptides (Fig. 4 A), but they
become broader upon addition of Zn2þ (Fig. 4 B). The
observed changes in the spectra indicate the formation of
a complex of rat Ab(1–16) with Zn2þ ions. The nature of
the zinc-induced line-broadening for various soluble forms
of Ab was previously examined in detail (5,10,12,51). It
FIGURE 4 Low-field region of the 600 MHz 1H NMR spectra of the rat
Ab(1–16) in its free state (A) and after addition of a twofold molar excess of
ZnCl2 (B). Spectra were collected at 10
C in Tris-d11, 90 H2O/10% D2O,
pH 7.1.
TABLE 1 Thermodynamic parameters of zinc ions binding to
rat Ab(1–16) and its mutants obtained by ITC at 25C in 50 mM
Tris buffer, pH 7.3
Peptide N Ka  104 (M1) DH (kcal M1) TDS (kcal M1)
Wt 0.60 1.53 4.8 0.9
D1A 0.70 0.98 3.5 1.9
E3A 1.20 0.71 1.8 3.6
H6A No binding
D7A 0.70 1.01 2.9 2.6
E11A 1.00 1.44 1.4 4.3
H14A No binding
Standard deviations of binding stoichiometry (N) and enthalpy (DH)
measurements do not exceed 10%, and those of the affinity constant (Ka)
measurements do not exceed 20%.
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exchange between different conformations of the Ab/Zn2þ
complex. Increasing the temperature makes the exchange
rates faster, and the observed NMR lines in the rat Ab(1–
16)/Zn2þ complex become sharper and similar to those
described for the rat Ab(1-28)/Zn2þ complex (10).
However, the temperature increase leads to a decrease in
the lifetime of each conformational state, an increase in
the exchange rates of amide protons with water, and an
increase in the amplitudes of the molecular motions. As
previously noted (10), none of these temperature-dependent
processes are favorable for obtaining structural information.
Therefore, we chose the optimal temperature range by
analogy with an earlier study on the human Ab(1–16)/
Zn2þ complex (5) in which all NMR measurements were
carried out at 278 K.
Sets of 2D homonuclear (NOESY, ROESY, TOCSY, and
DQF-COSY) and heteronuclear (13C-1H HSQC, HSQC-
TOCSY, HMBC, and 15N-1H HSQC) NMR spectra were
collected for the free Ab(1–16) and its complex with Zn2þ
at the natural abundance of the 13C and 15N isotopes. Reso-
nance assignments for nearly all 1H and 13C nuclei were
determined for rat Ab(1–16) in both the free state (Table
S1) and in its complex with zinc (Table S2). For free
Ab(1–16), we were able to obtain 15N resonance assign-
ments for the backbone and side-chain amide groups, but
we could not obtain such information for the complex of
rat Ab(1–16) with Zn2þ at the natural abundance of 15N
due to substantial zinc-induced signal broadening.
An analysis of the changes in chemical shifts of rat Ab(1–
16) observed upon zinc binding (Fig. S7) highlights two His
residues (His-6 and His-14) that participate in the metal ioncoordination. Significant broadening of the resonances of
Hε1 of these His residues upon addition of Zn2þ to the
peptide (Fig. S8) also confirms this conclusion. However,
due to the high mobility of the rat Ab(1–16) in solution,
zinc-induced changes of the chemical shifts are relatively
small and could not be used for unambiguous identification
of other residues that form the metal-binding site. ITC
studies on a set of rat Ab(1–16) alanine mutants were
used to determine the amino acids that take part in zinc coor-
dination (Fig. 2 and Fig. S1). ITC also provided information
about the stoichiometry and energy of zinc binding (Table 1).
Zinc binding to Ab(1–16) and its alanine mutants is both
enthalpy-driven and entropically favorable. The stoichiom-
etry of Zn2þ binding to all mutants except E3A is ~1:2
(Table 1), indicating that a peptide dimer containing one
Zn2þ ion is formed. At the same time, the stoichiometry
of Zn2þ binding to E3A is close to one, suggesting that
substitution of Glu-3 by Ala provides an opportunity to
gain favorable hydrophobic contacts within a monomer
upon Zn2þ binding. This is also in good agreement with
the highest favorable entropy of zinc binding for this mutant
in comparison with the other mutants. It can be seen that
substitution of Asp-1, Glu-3, and Asp-7 to Ala does not
substantially affect Zn2þ affinity for Ab(1–16), indicating
that these residues do not participate in metal coordination.
In contrast, during titration of the H6A and H14A mutants
with Zn2þ ions, no heat exchange was detected, signifying
that these His residues chelate Zn2þ. Thus, the ITC studies
unambiguously show that residues His-6 and His-14 coordi-
nate the zinc ion, and that rat Ab(1–16) dimerizes upon
metal chelation. This information was used for the calcula-
tions of the structure of the rat Ab(1–16) complex with zinc.
Sets of distance and torsion angle restraints (Table 2), ob-
tained from an analysis of NMR spectra recorded at 278 K,
were used for the structure calculations of rat Ab(1–16) and
its complex with zinc. It should be noted that no long-range
NOEs exist in the NOESY spectra of rat Ab(1–16) and its
complex with Zn2þ, which is typical for small, flexible
peptides.
We calculated an NMR structure of the free peptide using
restrained MD and a protocol optimized to determine theBiophysical Journal 102(1) 136–143
TABLE 2 Numbers of NMR restraints used for the structure
calculations and the statistics of the calculated families of rat
Ab(1–16) structures
Rat Ab(1–16)
Dimer of rat
Ab(1–16)/Zn2þ
Number of NOE restraints 111 120
Intraresidue 55 72
Sequential 45 33
Medium-range 11 15
Long-range (ji-jj>4) 0 0
Number of dihedral angle restraints 0 3
Number of Zn-chelating restraints 0 8
Ramachandran map statistic
Residues in most favored regions (%) 79.8 68.1
Residues in disallowed regions (%) 0.0 0.0
Number of conformers in a family
of structures
40 20
Number of NOE violations (>0.5 A˚)
per structure
2 0
RMSD of coordinates of atoms C0,
Ca, and N for superposition of
the family of structures (A˚)
2.315 0.55 1.465 0.48
FIGURE 5 Structure of the rat Ab(1–16) dimer complexed with Zn ions
in solution (the 20 NMR conformers have been deposited in the Protein
Data Bank with accession code 2LI9). Only the backbone atoms (Ca, C,
and N) and the side chains of the His residues are shown. Chains A and
B of the dimer are shown in red and blue, respectively. The N- and
C-termini of both chains are labeled. (A) The family of 20 calculated
NMR structures. (B) Coordination of the zinc ion by the histidine residues
in the representative structure after additional QM/MM geometry optimiza-
tion. The average distance between the Zn2þ ion and the nitrogen atoms of
the His residues (Nd1 and Nε2) is 2.075 0.05 A˚.
140 Istrate et al.structure of flexible peptides (33). An explicit water envi-
ronment was used for more-accurate calculations of the
electrostatic interactions between the charged peptide
groups. The family of NMR structures of the free rat
Ab(1–16) is relatively loose (the RMSD of coordinates of
heavy backbone atoms (C0, Ca, N, and O) is 2.31 5
0.55 A˚; Fig. S5 A). When the two terminal parts of the
peptide are superimposed, the RMSD becomes smaller
(1.98 5 0.36 A˚ for the N-terminal (1–6) and 1.66 5
0.36 A˚ for the C-terminal (7–16)), which is compatible
with the existence of two small subdomains (Fig. S6) and
a more flexible linker between them.
We calculated the NMR structures of the rat Ab(1–16)
dimer complexed with Zn2þ (Fig. 5) using the NMR
restraints for the free peptide and a set of distance
constraints between the zinc ion and His residues (Table
2). QM/MM calculations were carried out to optimize the
geometry of the Zn2þ coordination site. The constraints ob-
tained for the Zn-peptide interaction were used in the
restrained MD calculations. Amino acids that belong to
the different peptide chains in the Ab(1–16) dimer could
not be distinguished by their chemical shifts. Therefore,
two possible orientations of the peptide chains (parallel
and antiparallel) were tested in the structure calculations.
We found that only the parallel orientation (Fig. 5) fits the
set of NMR distance restraints. Structures calculated on
the assumption of an antiparallel chain orientation
(Fig. S9) have a much larger number of NOE violations.
Moreover, for an antiparallel dimer, one would also expect
to see several well-resolved interchain NOEs, which were
absent in the NOESY spectra. Fig. 5 A represents a final
family of 20 calculated NMR structures. (The bundle of
20 conformers representing the NMR structure has been
deposited in the Protein Data Bank with accession codeBiophysical Journal 102(1) 136–1432LI9, and the assignments are in the Biological Magnetic
Resonance Bank (ID 17884)). The RMSD of the coordinates
of the heavy backbone atoms (Ca, C0, and N) of the whole
dimer is 1.465 0.48 A˚, and for separate superpositions of
each chain the RMSDs are 1.13 5 0.59 A˚ (chain A) and
1.06 5 0.27 A˚ (chain B).
A representative structure of this family was subjected to
an additional QM/MM optimization step (Fig. 5 B). The
final structure, fixed by the His-metal interactions, is irreg-
ular and consists of bend, coil, and turn regions with no
other regular secondary structural elements such as helices
NMR Structure of Rat Ab(1–16) 141and b-strands. The side chains of the hydrophobic residues
Phe-4, Phe-10, and Val-12 are oriented outward from the
dimerization interface and do not interact with each other,
in contrast to the human Ab(1–16), where Phe-4 and Tyr-
10 form a hydrophobic contact (5). As noted above, the
two peptide chains in the dimer structure of rat Ab(1–16)
are packed in a parallel manner, with their N-terminal frag-
ments being close to each other. At the same time, the
C-tails of the two polypeptide chains in the rat Ab(1–16)
dimer are oriented in opposite directions to each other
(Fig. 5 A). It should also be emphasized that only the His
residues participate in zinc ion coordination by the rat
Ab(1–16), despite the presence of several other potential
chelating residues (Asp and Glu). This distinguishes rat
Ab(1–16) from its human analog, where His-6, Glu-11,
His-13, and His-14 form the coordination sphere of the
metal ion under similar experimental conditions (5). The
structural distinction between the zinc complexes of
the human and rat Ab(1–16) is clearly confirmed by the
differences in the distribution and number of NOEs in the
corresponding NMR spectra recorded under identical
conditions (Fig. S10). The ITC data also show reproducible
differences in the stoichiometry of zinc binding to rat (Table
1) and human (7) Ab(1–16).
An important feature of the behavior of the Ab(1–16)
peptides both in the free state and complexed with zinc is
the relatively fast (on the NMR timescale) exchange
between several conformational states. This feature was
previously discussed in terms of the zinc-induced line-
broadening observed in human and rat Ab(1–28) (10). In
earlier studies, investigators established the existence of
the free human peptides Ab(1-40) (52) and Ab(1-42) (53)
in water solution as an ensemble of distinct conformational
species undergoing fast exchange between each other, using
replica-exchange MD simulations based on NMR-derivedexperimental data. They found that several structured
regions exist in these peptides; otherwise, the peptide chains
are flexible. NMR and MD studies of the Cu2þ-binding sites
in human Ab(1-40) fibrils indicated the coexistence of
several peptide conformations and metal coordination
modes even in the solid state (8). It was proposed that
conformational selection and the resulting population shift
could provide a primary molecular mechanism for the
transformation of monomeric Ab into organized fibril
geometries (19).
The energetically favorable coordination of the zinc ion
by two rat Ab(1–16) molecules results in the formation of
a stable, well-defined dimer structure (Fig. 5) that corre-
sponds to the most populated conformational state of the
molecular complex. However, the observed zinc-induced
line-broadening in the complex of rat Ab(1–16) with Zn2þ
indicates the presence of some minor species with different
structures relative to the most populated conformers. For an
ensemble of conformational states, all of the NMR and ITC
parameters are weighted by the population of each state. It
should be noted that the measured stoichiometry of zinc
binding (0.60 5 0.06) is a little greater than the value ex-
pected for a dimer (N ¼ 0.5). This may reflect the existence
of a small population of monomeric states (N ¼ 1) in the
conformational ensemble.
According to current knowledge, fibril nucleation path-
ways include interactions of the metal-binding domains of
neighboring Ab molecules followed by the aggregation of
hydrophobic chains Ab(17-42) into a polymeric amyloid
structure (18,19,54). One can assume that the opposite
orientation of the two C-tails in the rat Ab(1–16) dimer, con-
strained by the zinc ion, will hinder the assembly of Ab
dimers into oligomeric aggregates (Fig. 6).
In contrast, the conformation of the human Ab(1–16) in
its complex with zinc (5) allows its C-tail to achieve anFIGURE 6 Structural differences between
human and rat Ab that may control the molecular
mechanism of rodents’ resistance to AD. Full-
length Ab with the metal-binding domains, pre-
sented as curves, are shown. The N- and C-termini
of the Ab chains are labeled.
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ordered amyloid aggregates (18). The EVHH fragment of
the human Ab (residues 11–14) forms the primary metal-
binding site (7). This fragment contains three potential
chelating amino acids, in contrast to its analogous fragment,
EVRH, in rat Ab, which has only two such groups. This
additional group in human Ab (His-13) could be responsible
for the monomer cross-linking, as suggested by earlier
studies of Ab aggregation (13,55). In the absence of this
residue in rat Ab(1–16), the most energetically favorable
coordination of the zinc ion is attained only by dimer forma-
tion at the very first stage. This presumably prevents further
nucleation of the metal-binding domains and subsequent
oligomerization of the whole rat Ab.CONCLUSIONS
NMR and ITC studies of the interactions of the rat Ab
metal-binding domain with a zinc ion, described here and
compared with earlier published results on the human Ab
domain, show clear differences between the rat and human
domains in the set of residues that coordinate the zinc ion,
and in the structural organization of the zinc-peptide
complex under close-to-physiological conditions. Thus,
the observed differences between human and rat Ab(1–16)
in the structure of zinc-binding sites, the ability to form
regular cross-monomer interactions, and the orientation of
the hydrophobic C-tails could be responsible for rats’ resis-
tance to AD.SUPPORTING MATERIAL
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